文献速递心血管USMR

超声心动图与心脏MRI测量癌症疑似心脏毒性患者左心室射血分数的比较

Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity.
PubMed 文献 · Radiol Cardiothorac Imaging · 2024-01-01

这项前瞻性单中心观察性队列研究纳入745例癌症疑似心脏毒性患者,同日行二维超声与心脏MRI。二维超声与MRI的LVEF平均偏差-3.7%,在50%阈值下9.3%患者分类不一致;74例亚组中三维超声与MRI一致性优于二维超声(P=0.016)。

要点

  • 二维超声与心脏MRI测LVEF平均偏差-3.7%,95%一致性界限-18.5%至11.1%。
  • 以50%为心脏毒性阈值,二维超声与MRI对9.3%患者分类不一致。
  • 三维超声与MRI一致性优于二维超声(P=0.016),作者建议三维超声作为一线影像。

核心结论

  • 在癌症疑似心脏毒性患者中,二维超声测LVEF与心脏MRI相比存在约±15%的变异,并导致约10%患者心脏毒性检测分类错误;三维超声与心脏MRI一致性更好,作者建议将其作为一线影像。

研究设计与样本

  • 前瞻性单中心观察性队列研究,2011年至2021年纳入745例癌症疑似心脏毒性患者,同日行二维超声心动图和心脏MRI,图像质量欠佳者被排除;其中74例亚组同时行三维超声心动图。

诊断标准与关键数值

  • 二维超声与心脏MRI的LVEF平均偏差-3.7%±7.6(95%一致性界限-18.5%至11.1%);在50% LVEF心脏毒性检测阈值下,9.3%患者两种方法分类不一致;74例亚组中MRI、三维超声、二维超声的平均LVEF分别为60.0%±10.4、58.4%±9.4、57.2%±8.9(P<.001);三维超声与MRI平均偏差-1.6%±6.3(95%一致性界限-13.9%至10.7%),优于二维超声与MRI的平均偏差-2.8%±6.3(95%一致性界限-15.2%至9.6%)(P=.016)。

临床应用与阅片要点

  • 作者认为三维超声与心脏MRI一致性更好,应作为一线影像;二维超声测LVEF与心脏MRI相比存在约±15%变异,在50%阈值下约10%患者心脏毒性检测分类不一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare left ventricular ejection fraction (LVEF) measured with echocardiography and cardiac MRI in individuals with cancer and suspected cardiotoxicity and assess the potential effect on downstream clinical decision-making. Materials and Methods In this prospective, single-center observational cohort study, participants underwent same-day two-dimensional (2D) echocardiography and cardiac MRI between 2011 and 2021. Participants with suboptimal image quality were excluded. A subset of 74 participants also underwent three-dimensional (3D) echocardiography. The agreement of LVEF derived from each modality was assessed using Bland-Altman analysis and at relevant thresholds for cardiotoxicity. Results A total of 745 participants (mean age, 60 years ± 5 [SD]; 460 [61.7%] female participants) underwent same-day echocardiography and cardiac MRI. According to Bland-Altman analysis, the mean bias was -3.7% ± 7.6 (95% limits of agreement [LOA]: -18.5% to 11.1%) for 2D echocardiography versus cardiac MRI. In 74 participants who underwent cardiac MRI, 3D echocardiography, and 2D echocardiography, the mean LVEFs were 60.0% ± 10.4, 58.4% ± 9.4, and 57.2% ± 8.9, respectively (P < .001). At the 50% LVEF threshold for detection of cardiotoxicity, there was disagreement for 9.3% of participants with 2D echocardiography and cardiac MRI. Agreement was better with 3D echocardiography and cardiac MRI (mean bias, -1.6% ± 6.3 [95% LOA: -13.9% to 10.7%]) compared with 2D echocardiography and cardiac MRI (mean bias, -2.8% ± 6.3 [95% LOA: -15.2% to 9.6%]; P = .016). Conclusion Two-dimensional echocardiography had variations of ±15% for LVEF measurement compared with cardiac MRI in participants with cancer and led to misclassification of approximately 10% of participants for cardiotoxicity detection. Three-dimensional echocardiography had better agreement with cardiac MRI and should be used as first-line imaging. Keywords: Echocardiography, MR Functional Imaging, Cardiac Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Nazir MS, Okafor J, Murphy T, et al. Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity. Radiol Cardiothorac Imaging. 2024. PMID: 38206164. doi:10.1148/ryct.230048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。